Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action

Dr Pinney reported receiving personal fees from Abbott, ADI, Ancora, BMS, CareDx, Cordio, Impulse Dynamics, Medtronic, Nuwellis, Restore Medical, Transmedics, and Valgen Medtech and nonfinancial support from Procyrion outside the submitted work. Dr Lala reported receiving grants from AstraZeneca, Cordio, and Merck and personal fees from Bayer, Novo Nordisk, Boehringer Ingelheim, and Zoll, and data safety monitoring board fees from Sequana outside the submitted work. Dr Stewart reported being a clinical events committee member of Procyrion and receiving consulting fees from Abbott outside the submitted work. Dr Morris reported receiving personal fees from Abbott, Boehringer Ingelheim, Lilly, Cytokinetics, Merck, Novo Nordisk, and Regeneron and grants from Merck outside the submitted work. Dr Pagani reported receiving advisory fees from BrioHealth Solutions outside the submitted work. Dr Stevenson reported receiving nonfinancial support from Endotronix Inc and modest trial research support to Vanderbilt University on a topic outside the submitted work. Dr Allen reported receiving grants from Patient-Centered Outcomes Research Institute, grants from the National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI), and personal fees from ACI Clinical, Quidel, and UpToDate outside the submitted work. Dr Breathett reported receiving grants from Indiana University and NHLBI outside the submitted work. Dr Cogswell reported receiving speaker fees from Abbott outside the submitted work. Dr Cowger reported receiving advisor, consulting, and/or speaker fees from Abbott, Medtronic, BrioHealth Solutions, Zoll, Procyrion, AstraZeneca and Endotronix outside the submitted work. Dr Drakos reported receiving consulting fees from Abbott and grants from Novartis outside the submitted work. Dr Kanwar reported receiving advisory board, speaker, and/or consulting fees from Abiomed, Abbott, Bivacor, and Corwave outside the submitted work. Dr Kiernan reported receiving nonfinancial support from Endotronix outside the submitted work. Dr Lewis reported receiving personal fees from AstraZeneca, Intellia, Merck, and Dal-Cor and grants from Idorsia, American Heart Association, and the National Institutes of Health outside the submitted work. Dr Ogunniyi reported receiving grants from AstraZeneca (Institutional Research Support), Boehringer Ingelheim (Institutional Research Grant Support), Pfizer (Institutional Research Grant Support), and personal fees from Novartis (Clinical Trial Steering Committee) outside the submitted work. Dr Pandey reported receiving research support from the National Institute of Health; grant funding from Applied Therapeutics and Gilead Sciences; honoraria outside of the present study as an advisor/consultant for Tricog Health Inc, Lilly USA, Rivus, Cytokinetics, Roche Diagnostics, Axon therapies, Medtronic, Edward Lifesciences, Science37, Novo Nordisk, Bayer, Merck, Sarfez Pharmaceuticals, and Emmi Solutions; nonfinancial support from Pfizer and Merck; and consultant fees/stock options for Palomarin Inc. Dr Tedford reported receiving personal fees from Abbott, Acorai, Adona, Aria CV (stock options), Merck, Alleviant, Boston Scientific, Cytokinetics, Edwards LifeSciences, Gradient, Medtronic, Morphic, Restore, TempusAI, United Therapeutics, Endotronix, and travel reimbursement from Abiomed outside the submitted work. Dr DeFilippis reported receiving personal fees from AstraZeneca and serving as trial committee member for Abiomed outside the submitted work. Dr Dixon reported receiving grants from American College of Cardiology, the Association of Black Cardiologists, and Bristol Myers Squibb during the conduct of the study. Dr Golbus reported receiving grants from the NHLBI outside the submitted work. Dr Gulati reported receiving travel support from Abiomed outside the submitted work. Dr Hanff reported receiving grants from Abiomed via International Society for Heart and Lung Transplantation outside the submitted work. Dr Nayak reported being a clinical advisory board member for PumpinHeart Ltd and receiving consultant fees from Alira Health outside the submitted work. No other disclosures were reported.